Loading...
Identification of CD4(+) T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system of autoimmune etiopathogenesis, and is characterized by various neurological symptoms. Glatiramer acetate and interferon-β are administered as first-line treatments for this disease. In non-responsive patients, s...
Na minha lista:
| Udgivet i: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580020/ https://ncbi.nlm.nih.gov/pubmed/31180553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10283 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|